Related Experiment Video
Updated: Jun 17, 2026

10:05
Hydrogel Nanoparticle Harvesting of Plasma or Urine for Detecting Low Abundance Proteins
Published on: August 7, 2014
Identification of Anaplasma centrale major surface protein-2 pseudogenes
T Molad1, B Leibovich, M Mazuz
1Division of Parasitology, Kimron Veterinary Institute, P. O. Box 12, Bet Dagan 50250, Israel. moladt@int.gov.il
Veterinary Microbiology
|December 29, 2009
Summary
This study identified unique MSP2 variants and pseudogenes in the Anaplasma centrale vaccine strain. These findings advance the development of novel vaccines against anaplasmosis by understanding antigenic variation mechanisms.
Area of Science:
- Veterinary Microbiology
- Molecular Biology
- Immunology
Background:
- Anaplasmosis is a tick-borne disease caused by Anaplasma species.
- Antigenic variation of MSP2 is crucial for Anaplasma survival and immune evasion.
- Understanding MSP2 variation in vaccine strains is key for improving anaplasmosis control.
Purpose of the Study:
- To identify msp2 pseudogenes and MSP2 variants in the Anaplasma centrale vaccine strain.
- To elucidate the mechanisms of MSP2 variant generation in A. centrale.
- To compare the A. centrale MSP2 repertoire with that of Anaplasma marginale.
Main Methods:
- Bioinformatic identification of msp2 pseudogenes in the A. centrale genome.
- Sequence alignment to analyze MSP2 variants and pseudogene structures.
- Comparison of MSP2 variant generation mechanisms with Anaplasma marginale.
Main Results:
- Five truncated msp2 pseudogenes were identified in A. centrale.
- Multiple MSP2 variants were detected during acute and persistent infections.
- MSP2 variants are generated by whole pseudogene recombination and segmental gene conversion.
- The A. centrale MSP2 repertoire differs from A. marginale, with unique variants and pseudogenes.
Conclusions:
- The identified MSP2 variants and pseudogenes in A. centrale are distinct from A. marginale.
- Unique genetic elements in the vaccine strain may explain superinfection permissiveness.
- This research contributes to developing next-generation anaplasmosis vaccines.

